CHRISTINA DOLINAR: Open Payments
NPI 1730223363 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 41 payments from 14 companies in 2025. Trend: 2023 $1,213 · 2024 $575 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $211 |
| ABBVIE INC. | 10 | $170 |
| Regeneron Healthcare Solutions, Inc. | 3 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Arcutis Biotherapeutics, Inc. | 4 | $66 |
| Organon LLC | 3 | $49 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $41 |
| KYOWA KIRIN, INC. | 2 | $38 |
Products named: Bimzelx, DUPIXENT, RINVOQ, Zoryve, COSENTYX, SKYRIZI, CIBINQO, POTELIGEO.
Industry payments across NC — which companies pay providers there.
